Yun Jung Choi

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

Zhenfeng Zhang, Jae Cheol Lee, Luping Lin et al. · Nature Genetics · 2012 · 1.2K citations · Full text

Oncology, Axl Kinase, Egfr-targeted Therapy +8

Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer

Dong Ha Kim, HyeongRyul Kim, Yun Jung Choi et al. · Experimental & Molecular Medicine · 2019 · 377 citations · Full text

MET and AXL Inhibitor NPS-1034 Exerts Efficacy against Lung Cancer Cells Resistant to EGFR Kinase Inhibitors Because of MET or AXL Activation

Jin Kyung Rho, Yun Jung Choi, Seon Ye Kim et al. · Cancer Research · 2013 · 143 citations

Met Activation, Oncology, Axl Activation +15

Epithelial‐mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4‐ALK translocation

Hyeong Ryul Kim, Woo Sung Kim, Yun Jung Choi et al. · Molecular Oncology · 2013 · 112 citations · Full text

Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c‐kit‐expression in a Fas/FasL‐ and p53‐independent manner

Yun Jung Choi, Do-Won Ok, Dueg-Nam Kwon et al. · FEBS Letters · 2004 · 110 citations